Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CHAPTER II Study - Congenital Heart Adolescents Participating in Transition Evaluation Research

NCT01723332 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT01723332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01723332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CHAPTER II Study - Congenital Heart Adolescents Participating in Transition Evaluation Research
Lead sponsor
University of Alberta
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2012
Completion date
December 1, 2016
Enrollment
120 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease